Global Exosome Diagnostics and Therapeutics Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Exosome Diagnostics and Therapeutics market size was estimated at USD 180.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 34.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Exosome Diagnostics and Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Exosome Diagnostics and Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Exosome Diagnostics and Therapeutics market.
Global Exosome Diagnostics and Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Market Segmentation (by Type)
Instrument
Reagent
Software
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Exosome Diagnostics and Therapeutics Market
Overview of the regional outlook of the Exosome Diagnostics and Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Exosome Diagnostics and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Exosome Diagnostics and Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Exosome Diagnostics and Therapeutics market size was estimated at USD 180.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 34.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Exosome Diagnostics and Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Exosome Diagnostics and Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Exosome Diagnostics and Therapeutics market.
Global Exosome Diagnostics and Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Market Segmentation (by Type)
Instrument
Reagent
Software
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Exosome Diagnostics and Therapeutics Market
Overview of the regional outlook of the Exosome Diagnostics and Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Exosome Diagnostics and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Exosome Diagnostics and Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Exosome Diagnostics and Therapeutics
1.2 Key Market Segments
1.2.1 Exosome Diagnostics and Therapeutics Segment by Type
1.2.2 Exosome Diagnostics and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Exosome Diagnostics and Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Exosome Diagnostics and Therapeutics Product Life Cycle
3.3 Global Exosome Diagnostics and Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Exosome Diagnostics and Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Exosome Diagnostics and Therapeutics Market Competitive Situation and Trends
3.8.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Exosome Diagnostics and Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Exosome Diagnostics and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Exosome Diagnostics and Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Exosome Diagnostics and Therapeutics Market Size by Type (2020-2025)
6.4 Global Exosome Diagnostics and Therapeutics Price by Type (2020-2025)
7 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Exosome Diagnostics and Therapeutics Market Sales by Application (2020-2025)
7.3 Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
8 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SALES BY REGION
8.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Region
8.2 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.2.1 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.2.2 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Exosome Diagnostics and Therapeutics Sales by Country
8.3.2 North America Exosome Diagnostics and Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Exosome Diagnostics and Therapeutics Sales by Country
8.4.2 Europe Exosome Diagnostics and Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region
8.5.2 Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Exosome Diagnostics and Therapeutics Sales by Country
8.6.2 South America Exosome Diagnostics and Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region
8.7.2 Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Exosome Diagnostics and Therapeutics by Region(2020-2025)
9.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Exosome Diagnostics and Therapeutics Production
9.4.1 North America Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Exosome Diagnostics and Therapeutics Production
9.5.1 Europe Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Exosome Diagnostics and Therapeutics Production (2020-2025)
9.6.1 Japan Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Exosome Diagnostics and Therapeutics Production (2020-2025)
9.7.1 China Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Aethlon Medical(US)
10.1.1 Aethlon Medical(US) Basic Information
10.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
10.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.1.4 Aethlon Medical(US) Business Overview
10.1.5 Aethlon Medical(US) SWOT Analysis
10.1.6 Aethlon Medical(US) Recent Developments
10.2 Exosome Diagnostics(US)
10.2.1 Exosome Diagnostics(US) Basic Information
10.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
10.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.2.4 Exosome Diagnostics(US) Business Overview
10.2.5 Exosome Diagnostics(US) SWOT Analysis
10.2.6 Exosome Diagnostics(US) Recent Developments
10.3 NanoSomix Inc.(US)
10.3.1 NanoSomix Inc.(US) Basic Information
10.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
10.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.3.4 NanoSomix Inc.(US) Business Overview
10.3.5 NanoSomix Inc.(US) SWOT Analysis
10.3.6 NanoSomix Inc.(US) Recent Developments
10.4 Thermo Fisher Scientific (US)
10.4.1 Thermo Fisher Scientific (US) Basic Information
10.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
10.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.4.4 Thermo Fisher Scientific (US) Business Overview
10.4.5 Thermo Fisher Scientific (US) Recent Developments
10.5 Malvern Instruments (UK)
10.5.1 Malvern Instruments (UK) Basic Information
10.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
10.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Market Performance
10.5.4 Malvern Instruments (UK) Business Overview
10.5.5 Malvern Instruments (UK) Recent Developments
10.6 System Biosciences(US)
10.6.1 System Biosciences(US) Basic Information
10.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
10.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.6.4 System Biosciences(US) Business Overview
10.6.5 System Biosciences(US) Recent Developments
10.7 NX Pharmagen (US)
10.7.1 NX Pharmagen (US) Basic Information
10.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
10.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.7.4 NX Pharmagen (US) Business Overview
10.7.5 NX Pharmagen (US) Recent Developments
10.8 Sistemic Inc(UK)
10.8.1 Sistemic Inc(UK) Basic Information
10.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
10.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Market Performance
10.8.4 Sistemic Inc(UK) Business Overview
10.8.5 Sistemic Inc(UK) Recent Developments
10.9 Capricor Therapeutics (US)
10.9.1 Capricor Therapeutics (US) Basic Information
10.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
10.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.9.4 Capricor Therapeutics (US) Business Overview
10.9.5 Capricor Therapeutics (US) Recent Developments
10.10 Exiqon A/S (Denmark)
10.10.1 Exiqon A/S (Denmark) Basic Information
10.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
10.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Market Performance
10.10.4 Exiqon A/S (Denmark) Business Overview
10.10.5 Exiqon A/S (Denmark) Recent Developments
11 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast
11.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region
11.2.4 South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Exosome Diagnostics and Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Exosome Diagnostics and Therapeutics by Type (2026-2035)
12.1.2 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Exosome Diagnostics and Therapeutics by Type (2026-2035)
12.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Exosome Diagnostics and Therapeutics
1.2 Key Market Segments
1.2.1 Exosome Diagnostics and Therapeutics Segment by Type
1.2.2 Exosome Diagnostics and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Exosome Diagnostics and Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Exosome Diagnostics and Therapeutics Product Life Cycle
3.3 Global Exosome Diagnostics and Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Exosome Diagnostics and Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Exosome Diagnostics and Therapeutics Market Competitive Situation and Trends
3.8.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Exosome Diagnostics and Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Exosome Diagnostics and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Exosome Diagnostics and Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Exosome Diagnostics and Therapeutics Market Size by Type (2020-2025)
6.4 Global Exosome Diagnostics and Therapeutics Price by Type (2020-2025)
7 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Exosome Diagnostics and Therapeutics Market Sales by Application (2020-2025)
7.3 Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
8 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SALES BY REGION
8.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.1 Global Exosome Diagnostics and Therapeutics Sales by Region
8.1.2 Global Exosome Diagnostics and Therapeutics Sales Market Share by Region
8.2 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.2.1 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.2.2 Global Exosome Diagnostics and Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Exosome Diagnostics and Therapeutics Sales by Country
8.3.2 North America Exosome Diagnostics and Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Exosome Diagnostics and Therapeutics Sales by Country
8.4.2 Europe Exosome Diagnostics and Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region
8.5.2 Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Exosome Diagnostics and Therapeutics Sales by Country
8.6.2 South America Exosome Diagnostics and Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region
8.7.2 Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Exosome Diagnostics and Therapeutics by Region(2020-2025)
9.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Exosome Diagnostics and Therapeutics Production
9.4.1 North America Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Exosome Diagnostics and Therapeutics Production
9.5.1 Europe Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Exosome Diagnostics and Therapeutics Production (2020-2025)
9.6.1 Japan Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Exosome Diagnostics and Therapeutics Production (2020-2025)
9.7.1 China Exosome Diagnostics and Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Exosome Diagnostics and Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Aethlon Medical(US)
10.1.1 Aethlon Medical(US) Basic Information
10.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
10.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.1.4 Aethlon Medical(US) Business Overview
10.1.5 Aethlon Medical(US) SWOT Analysis
10.1.6 Aethlon Medical(US) Recent Developments
10.2 Exosome Diagnostics(US)
10.2.1 Exosome Diagnostics(US) Basic Information
10.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
10.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.2.4 Exosome Diagnostics(US) Business Overview
10.2.5 Exosome Diagnostics(US) SWOT Analysis
10.2.6 Exosome Diagnostics(US) Recent Developments
10.3 NanoSomix Inc.(US)
10.3.1 NanoSomix Inc.(US) Basic Information
10.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
10.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.3.4 NanoSomix Inc.(US) Business Overview
10.3.5 NanoSomix Inc.(US) SWOT Analysis
10.3.6 NanoSomix Inc.(US) Recent Developments
10.4 Thermo Fisher Scientific (US)
10.4.1 Thermo Fisher Scientific (US) Basic Information
10.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
10.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.4.4 Thermo Fisher Scientific (US) Business Overview
10.4.5 Thermo Fisher Scientific (US) Recent Developments
10.5 Malvern Instruments (UK)
10.5.1 Malvern Instruments (UK) Basic Information
10.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
10.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Market Performance
10.5.4 Malvern Instruments (UK) Business Overview
10.5.5 Malvern Instruments (UK) Recent Developments
10.6 System Biosciences(US)
10.6.1 System Biosciences(US) Basic Information
10.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
10.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Market Performance
10.6.4 System Biosciences(US) Business Overview
10.6.5 System Biosciences(US) Recent Developments
10.7 NX Pharmagen (US)
10.7.1 NX Pharmagen (US) Basic Information
10.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
10.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.7.4 NX Pharmagen (US) Business Overview
10.7.5 NX Pharmagen (US) Recent Developments
10.8 Sistemic Inc(UK)
10.8.1 Sistemic Inc(UK) Basic Information
10.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
10.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Market Performance
10.8.4 Sistemic Inc(UK) Business Overview
10.8.5 Sistemic Inc(UK) Recent Developments
10.9 Capricor Therapeutics (US)
10.9.1 Capricor Therapeutics (US) Basic Information
10.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
10.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Market Performance
10.9.4 Capricor Therapeutics (US) Business Overview
10.9.5 Capricor Therapeutics (US) Recent Developments
10.10 Exiqon A/S (Denmark)
10.10.1 Exiqon A/S (Denmark) Basic Information
10.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
10.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Market Performance
10.10.4 Exiqon A/S (Denmark) Business Overview
10.10.5 Exiqon A/S (Denmark) Recent Developments
11 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast
11.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region
11.2.4 South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Exosome Diagnostics and Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Exosome Diagnostics and Therapeutics by Type (2026-2035)
12.1.2 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Exosome Diagnostics and Therapeutics by Type (2026-2035)
12.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Exosome Diagnostics and Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 4. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 5. Exosome Diagnostics and Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Exosome Diagnostics and Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Exosome Diagnostics and Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2025)
Table 11. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Exosome Diagnostics and Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Exosome Diagnostics and Therapeutics Sales by Type (K Units)
Table 27. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 28. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Exosome Diagnostics and Therapeutics Market Share by Type (2020-2025)
Table 32. Global Exosome Diagnostics and Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Application
Table 34. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 35. Global Exosome Diagnostics and Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Exosome Diagnostics and Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Table 39. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025)
Table 44. North America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Exosome Diagnostics and Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Exosome Diagnostics and Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Aethlon Medical(US) Basic Information
Table 63. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
Table 64. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Aethlon Medical(US) Business Overview
Table 66. Aethlon Medical(US) SWOT Analysis
Table 67. Aethlon Medical(US) Recent Developments
Table 68. Exosome Diagnostics(US) Basic Information
Table 69. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
Table 70. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Exosome Diagnostics(US) Business Overview
Table 72. Exosome Diagnostics(US) SWOT Analysis
Table 73. Exosome Diagnostics(US) Recent Developments
Table 74. NanoSomix Inc.(US) Basic Information
Table 75. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
Table 76. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. NanoSomix Inc.(US) Business Overview
Table 78. NanoSomix Inc.(US) SWOT Analysis
Table 79. NanoSomix Inc.(US) Recent Developments
Table 80. Thermo Fisher Scientific (US) Basic Information
Table 81. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
Table 82. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific (US) Business Overview
Table 84. Thermo Fisher Scientific (US) Recent Developments
Table 85. Malvern Instruments (UK) Basic Information
Table 86. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
Table 87. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Malvern Instruments (UK) Business Overview
Table 89. Malvern Instruments (UK) Recent Developments
Table 90. System Biosciences(US) Basic Information
Table 91. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
Table 92. System Biosciences(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. System Biosciences(US) Business Overview
Table 94. System Biosciences(US) Recent Developments
Table 95. NX Pharmagen (US) Basic Information
Table 96. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
Table 97. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. NX Pharmagen (US) Business Overview
Table 99. NX Pharmagen (US) Recent Developments
Table 100. Sistemic Inc(UK) Basic Information
Table 101. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
Table 102. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sistemic Inc(UK) Business Overview
Table 104. Sistemic Inc(UK) Recent Developments
Table 105. Capricor Therapeutics (US) Basic Information
Table 106. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
Table 107. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Capricor Therapeutics (US) Business Overview
Table 109. Capricor Therapeutics (US) Recent Developments
Table 110. Exiqon A/S (Denmark) Basic Information
Table 111. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
Table 112. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Exiqon A/S (Denmark) Business Overview
Table 114. Exiqon A/S (Denmark) Recent Developments
Table 115. Global Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Exosome Diagnostics and Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Exosome Diagnostics and Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 4. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 5. Exosome Diagnostics and Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Exosome Diagnostics and Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Exosome Diagnostics and Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2025)
Table 11. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Exosome Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Exosome Diagnostics and Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Exosome Diagnostics and Therapeutics Sales by Type (K Units)
Table 27. Global Exosome Diagnostics and Therapeutics Market Size by Type (M USD)
Table 28. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Exosome Diagnostics and Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Exosome Diagnostics and Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Exosome Diagnostics and Therapeutics Market Share by Type (2020-2025)
Table 32. Global Exosome Diagnostics and Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Exosome Diagnostics and Therapeutics Sales (K Units) by Application
Table 34. Global Exosome Diagnostics and Therapeutics Market Size by Application
Table 35. Global Exosome Diagnostics and Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Exosome Diagnostics and Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Table 39. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025)
Table 44. North America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Exosome Diagnostics and Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Exosome Diagnostics and Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Exosome Diagnostics and Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Exosome Diagnostics and Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Exosome Diagnostics and Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Exosome Diagnostics and Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Aethlon Medical(US) Basic Information
Table 63. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Overview
Table 64. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Aethlon Medical(US) Business Overview
Table 66. Aethlon Medical(US) SWOT Analysis
Table 67. Aethlon Medical(US) Recent Developments
Table 68. Exosome Diagnostics(US) Basic Information
Table 69. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Overview
Table 70. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Exosome Diagnostics(US) Business Overview
Table 72. Exosome Diagnostics(US) SWOT Analysis
Table 73. Exosome Diagnostics(US) Recent Developments
Table 74. NanoSomix Inc.(US) Basic Information
Table 75. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Overview
Table 76. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. NanoSomix Inc.(US) Business Overview
Table 78. NanoSomix Inc.(US) SWOT Analysis
Table 79. NanoSomix Inc.(US) Recent Developments
Table 80. Thermo Fisher Scientific (US) Basic Information
Table 81. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Overview
Table 82. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific (US) Business Overview
Table 84. Thermo Fisher Scientific (US) Recent Developments
Table 85. Malvern Instruments (UK) Basic Information
Table 86. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Overview
Table 87. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Malvern Instruments (UK) Business Overview
Table 89. Malvern Instruments (UK) Recent Developments
Table 90. System Biosciences(US) Basic Information
Table 91. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Overview
Table 92. System Biosciences(US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. System Biosciences(US) Business Overview
Table 94. System Biosciences(US) Recent Developments
Table 95. NX Pharmagen (US) Basic Information
Table 96. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Overview
Table 97. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. NX Pharmagen (US) Business Overview
Table 99. NX Pharmagen (US) Recent Developments
Table 100. Sistemic Inc(UK) Basic Information
Table 101. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Overview
Table 102. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sistemic Inc(UK) Business Overview
Table 104. Sistemic Inc(UK) Recent Developments
Table 105. Capricor Therapeutics (US) Basic Information
Table 106. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Overview
Table 107. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Capricor Therapeutics (US) Business Overview
Table 109. Capricor Therapeutics (US) Recent Developments
Table 110. Exiqon A/S (Denmark) Basic Information
Table 111. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Overview
Table 112. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Exiqon A/S (Denmark) Business Overview
Table 114. Exiqon A/S (Denmark) Recent Developments
Table 115. Global Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Exosome Diagnostics and Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Exosome Diagnostics and Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Exosome Diagnostics and Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Exosome Diagnostics and Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Exosome Diagnostics and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Exosome Diagnostics and Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Exosome Diagnostics and Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Exosome Diagnostics and Therapeutics Product Life Cycle
Figure 13. Exosome Diagnostics and Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Exosome Diagnostics and Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Exosome Diagnostics and Therapeutics
Figure 19. Global Exosome Diagnostics and Therapeutics Market PEST Analysis
Figure 20. Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Exosome Diagnostics and Therapeutics Market Share by Type
Figure 27. Sales Market Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Exosome Diagnostics and Therapeutics by Type in 2025
Figure 29. Market Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 30. Market Share of Exosome Diagnostics and Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Exosome Diagnostics and Therapeutics Market Share by Application
Figure 33. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Exosome Diagnostics and Therapeutics Market Share by Application in 2025
Figure 37. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 45. U.S. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Exosome Diagnostics and Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Exosome Diagnostics and Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Exosome Diagnostics and Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Exosome Diagnostics and Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 55. Germany Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region in 2024
Figure 68. China Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 82. Brazil Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Exosome Diagnostics and Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Exosome Diagnostics and Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Exosome Diagnostics and Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Exosome Diagnostics and Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Exosome Diagnostics and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Exosome Diagnostics and Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Exosome Diagnostics and Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Exosome Diagnostics and Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Exosome Diagnostics and Therapeutics Product Life Cycle
Figure 13. Exosome Diagnostics and Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Exosome Diagnostics and Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Exosome Diagnostics and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Exosome Diagnostics and Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Exosome Diagnostics and Therapeutics
Figure 19. Global Exosome Diagnostics and Therapeutics Market PEST Analysis
Figure 20. Global Exosome Diagnostics and Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Exosome Diagnostics and Therapeutics Market Share by Type
Figure 27. Sales Market Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Exosome Diagnostics and Therapeutics by Type in 2025
Figure 29. Market Share of Exosome Diagnostics and Therapeutics by Type (2020-2025)
Figure 30. Market Share of Exosome Diagnostics and Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Exosome Diagnostics and Therapeutics Market Share by Application
Figure 33. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Exosome Diagnostics and Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Exosome Diagnostics and Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Exosome Diagnostics and Therapeutics Market Share by Application in 2025
Figure 37. Global Exosome Diagnostics and Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Exosome Diagnostics and Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Exosome Diagnostics and Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 45. U.S. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Exosome Diagnostics and Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Exosome Diagnostics and Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Exosome Diagnostics and Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Exosome Diagnostics and Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 55. Germany Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Exosome Diagnostics and Therapeutics Market Size by Region in 2024
Figure 68. China Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Exosome Diagnostics and Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Exosome Diagnostics and Therapeutics Market Size by Country in 2024
Figure 82. Brazil Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Exosome Diagnostics and Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Exosome Diagnostics and Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Exosome Diagnostics and Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Exosome Diagnostics and Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Exosome Diagnostics and Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Exosome Diagnostics and Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Exosome Diagnostics and Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Exosome Diagnostics and Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Exosome Diagnostics and Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2026-2035)
